3CELERMAJER D S, SORENSEN K E, GOOCH V M, et al. Non invasive dectection of endothelial dysfunction in children and adults at risk of atherosclerosis[J]. Lancet,1992,340:1111-1115.
5CHOBANIAN A V, BAKRIS G L, BLACK H R,et al. The seventh report of the joint national committee on prevention, Detection, Evaluation, and Treatment of high blood pressure[J].JAMA,2003,289:2560 -2572.
6Practice Guidelines For Primary Care Physicians.2003 ESH / ESC Hypertension Guidelines[J]. J Hyperten, 2003,21:1779- 1786.
7The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic[J]. JAMA, 2002, 288:2981-2997.
8PITT B,REMME W,ZANNA F,et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction[J].N Engl J Med,2003,348:1309-1321.
9Fox KM: EURopean trial in reduction of cardiac events with perindopril in stable coronary artery disease investigatos. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind,placebo-controlled multicentre trial (the EUROPA study) [J]. Lancet, 2003,362 : 782- 788.
10ZWEIKER R, STOSCHITZKY K, MAIER R, et al.Efficacy and safety of the ACE-Inhibitor Imidapril in patients with essential hypertension[J]. Acta Med Austriaca, 2002,29:72- 76.
